Package Leaflet: Information for the User
Omeprazol farmaMabo 20 mg Hard Capsules
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Follow exactly the administration instructions contained in this leaflet or those given by your doctor or pharmacist.
1. What isOmeprazol farmaMaboand what it is used for
2. What you need to know before starting to takeOmeprazol farmaMabo
3. How to takeOmeprazol farmaMabo
4. Possible side effects
5. Storage ofOmeprazol farmaMabo
6. Contents of the pack and additional information
This medicationcontains omeprazole as its active ingredient. It belongs to a group of medications known as “proton pump inhibitors”. These medications work by reducing the amount of acid produced by the stomach.
This medicationis indicated for adults for the short-term treatment of symptoms of acid reflux (e.g., heartburn, acid regurgitation).
Acid reflux is the backflow of acid from the stomach into the esophagus, which can become inflamed and painful. This can cause symptoms such as a burning sensation in the chest that rises up to the throat (heartburn) and a sour taste in the mouth (acid regurgitation).
You may need to take the capsules for 2-3 consecutive days to achieve an improvement in symptoms.
You should consult a doctor if symptoms worsen or do not improve after 14 days.
Do not takeOmeprazol farmaMabo:
Do not takethis medicationif you fall into any of the above categories. If you are unsure, consult your doctor or pharmacist before takingomeprazole.
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medication.
Do not takethis medicationfor more than 14 days without consulting your doctor. If you do not experience relief, or if your symptoms worsen, consult your doctor.
This medicationmay mask the symptoms of other diseases. Therefore, consult your doctor immediately if you experience any of the following symptoms before starting to takethis medicationor during treatment:
If you experience a skin rash, especially in sun-exposed areas, consult your doctor as soon as possible, as it may be necessary to interrupt treatment with this medication. Remember to mention any other symptoms you may notice, such as joint pain.
When taking omeprazole, kidney inflammation may occur. Signs and symptoms may include decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. You should inform your doctor of these signs.
Patients should not take omeprazole as preventive medication.
Children and adolescents
Children and adolescents under 18 years old should not take this medication.
Taking Omeprazol farmaMabo with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. This includes medications purchased without a prescription. This is because omeprazole may affect the mechanism of action of some medications and some medications may affect this medication.
Do not take omeprazole if you are taking a medication that containsnelfinavir(used to treat HIV infection).
Inform your doctor or pharmacist if you are taking any of the following medications:
Taking Omeprazol farmaMabo with food and drinks
See section 3.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or if you think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Omeprazole passes into breast milk but is unlikely to affect the baby when used in therapeutic doses. Your doctor will decide if you can take this medication while breastfeeding.
Driving and operating machinery
This medicationis unlikely to affect your ability to drive or use tools or machines. However, side effects such as dizziness and visual disturbances (see section 4) may occur. If they do, you should not drive or operate machinery.
Omeprazol farmaMabo contains saccharose and sodium
This medication contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 23 mg of sodium (1 mmol) per capsule; it is essentially "sodium-free"..
Follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor or pharmacist.In case of doubt, ask your doctor or pharmacist.
The recommended dose is one 20 mg capsule once a day for 14 days. Contact your doctor if symptoms do not disappear after this time.
You may need to take the capsules for 2-3 consecutive days to achieve an improvement in symptoms.
How to take this medication
What to do if you have trouble swallowing the capsules
Use in children and adolescents
Children and adolescents under 18 years old should not take this medication.
If you take moreOmeprazol farmaMabothan you should
If you have taken more omeprazole than prescribed by your doctor, consult your doctor or pharmacist immediately. You can also call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
If you forget to takeOmeprazol farmaMabo
If you forget to take a dose, take it as soon as you remember. However, if there is little time left for the next dose, skip the missed dose. Do not take a double dose to compensate for the missed doses.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you experience any of the following rare but serious side effects, stop taking this medicine and consult your doctor immediately:
Other side effects are:
Frequent side effects (may affect up to 1 in 10 people)
Less frequent side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Unknown frequency(cannot be estimated from available data)
In very rare cases, this medicine can affect white blood cells in the blood and cause immunodeficiency. If you experience an infection with symptoms such as fever with a very poor general condition or fever with local infection symptoms, such as neck pain, throat pain, or mouth pain or difficulty urinating, you should consult your doctor as soon as possible to perform a blood test and rule out a lack of white blood cells (agranulocytosis). It is essential to provide information about the medicine you are taking at that time.
Do not worry about this list of possible side effects. You may not experience any of them. If you consider that any of the side effects you are experiencing are severe or if you experience any side effect not mentioned in this prospectus, inform your doctor or pharmacist.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Composition ofOmeprazol farmaMabo
Capsule:gelatin, titanium dioxide (E-171).
Printing ink: iron oxide black (E-172), potassium hydroxideandshellac.See section 2Omeprazol farmaMabo contains Saccharose.
Appearance of the product and contents of the packaging
Omeprazol farmaMabocapsules are hard gelatin capsules of white opaque color marked with “OM 20” that contain spherical granules.
PVC-PVDC/Al blister: 7 and 14 capsules.
Only some packaging sizes may be commercially marketed.
Marketing authorization holder and responsible manufacturer
MABO-FARMA S.A..
C/Rejas, plant 1
28821, Coslada (Madrid)
Spain
Responsible manufacturer
Towa Pharmaceutical Europe S.L.
C/Sant Marti, 75-97
08107, Martorelles (Barcelona) -
Spain
Last review date of this leaflet:March 2023
The detailed information of this medication is available on the website of theSpanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.